VEGFA and cancer: The laboratory of JY Chang has used this method to show an increased immune response of non-native isomers (X-isomers) to vascular endothelial growth factor (VEGF) in mice [18], demonstrating that X-VEGF isomers are potentially useful compounds for developing active immunotherapy for cancer treatment.